Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Intangible Assets, Net

v3.23.3
Note 13 - Intangible Assets, Net
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]

Note 13. Intangible Assets, net - Provisional

 

Intangible assets, net consisted of the following:

 

   

September 30, 2023

   

December 31, 2022

 
   

(Unaudited)

   

(Audited)

 

Pharmacy records

  $ 8,100,000     $ -  

Trade names

    4,060,000       -  

Developed technology

    2,560,000       -  

Customer Contracts

    250,000       250,000  

Subtotal

  $ 14,970,000     $ 250,000  

Less: accumulated amortization

    (853,252 )     (199,999 )

Net intangible assets

  $ 14,116,748     $ 50,001  

 

Amortization of customer contracts is included in depreciation and amortization in the accompanying Condensed Consolidated Statements of Comprehensive Income (Loss). For the nine months ended September 30, 2023 and 2022, the Company recognized amortization expense of approximately $0.7 million and $18,750, respectively. Future amortization of intangible assets is as follows:

 

Year

    Amount  

2023 (remaining three months)

  $ 640,748  

2024

    2,563,000  

2025

    2,538,000  

2026

    2,538,000  

2027

    2,538,000  

Thereafter

    3,299,000  

Total

  $ 14,116,748  

 

The increase in intangible assets was attributable to the consolidation of Progressive Care as of  July 1, 2023.